19261819

Source:http://linkedlifedata.com/resource/pubmed/id/19261819

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002007, umls-concept:C0022661, umls-concept:C0403447, umls-concept:C0449258, umls-concept:C0920317, umls-concept:C1292733, umls-concept:C1955832
pubmed:issue	3
pubmed:dateCreated	2009-3-13
pubmed:abstractText	Addition of aldosterone antagonists (AA) might provide renal benefits to proteinuric chronic kidney disease (CKD) patients over and above the inhibition of renin-angiotensin system blockers (RAS). We evaluated the benefits and harms of adding selective and nonselective AA in CKD patients already on RAS.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-10390455, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-10471456, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-11453706, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-11565518, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-11824855, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-12668699, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-12787440, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-12937319, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-12958120, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-14633117, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-15089793, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-15149345, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-15295047, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-16123474, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-16135776, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-16192423, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-16204281, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-16316360, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-16775595, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-17035949, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-17053552, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-17054288, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-17699214, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-17699311, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-17699327, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-17923591, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-17943159, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-17986697, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-18094029, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-18215698, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-18360019, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-18378520, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-18423812, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-20221225, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-3802833, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-7035596, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-8094898, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-8114857, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-8770880, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-9217756, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-9453344, http://linkedlifedata.com/resource/pubmed/commentcorrection/19261819-9478930
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101271570
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1555-905X
pubmed:author	pubmed-author:NavaneethanSankar DSD, pubmed-author:NigwekarSagar USU, pubmed-author:SehgalAshwini RAR, pubmed-author:StrippoliGiovanni F MGF
pubmed:issnType	Electronic
pubmed:volume	4
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	542-51
pubmed:dateRevised	2010-9-22
pubmed:meshHeading	pubmed-meshheading:19261819-Aldosterone Antagonists, pubmed-meshheading:19261819-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:19261819-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:19261819-Chronic Disease, pubmed-meshheading:19261819-Disease Progression, pubmed-meshheading:19261819-Drug Therapy, Combination, pubmed-meshheading:19261819-Glomerular Filtration Rate, pubmed-meshheading:19261819-Humans, pubmed-meshheading:19261819-Hyperkalemia, pubmed-meshheading:19261819-Kidney Diseases, pubmed-meshheading:19261819-Kidney Failure, Chronic, pubmed-meshheading:19261819-Proteinuria, pubmed-meshheading:19261819-Renin-Angiotensin System, pubmed-meshheading:19261819-Risk Assessment, pubmed-meshheading:19261819-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.
pubmed:affiliation	Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, Ohio 44195, USA. navanes@ccf.org
pubmed:publicationType	Journal Article, Review, Meta-Analysis